ha14-1 has been researched along with Hepatoblastoma in 1 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lieber, J | 1 |
Ellerkamp, V | 1 |
Wenz, J | 1 |
Kirchner, B | 1 |
Warmann, SW | 1 |
Fuchs, J | 1 |
Armeanu-Ebinger, S | 1 |
1 other study available for ha14-1 and Hepatoblastoma
Article | Year |
---|---|
Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells.
Topics: Apoptosis; Benzamides; Benzopyrans; Biphenyl Compounds; Blotting, Western; Cell Survival; Drug Resis | 2012 |